E-LIB Suche - Ergebnisse für: Delphine Loirat

1

Author Correction: Safety analyses from the phase 3 ASCENT ..:

Rugo, Hope S. ; Tolaney, Sara M. ; Loirat, Delphine...
npj Breast Cancer. 10 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

TROPION-Breast03: a randomized phase III global trial of da..:

Bardia, Aditya ; Pusztai, Lajos ; Albain, Kathy...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

3

Veliparib with carboplatin and paclitaxel in BRCA-mutated a..:

Diéras, Véronique ; Han, Hyo S. ; Wildiers, Hans...
European Journal of Cancer. 200 (2024) - p. 113580 , 2024

Link: https://doi.org/10.1016/..

4

Tolerance of Concurrent Adjuvant Radiation Therapy and Pemb..:

Tison, Thais ; Loap, Pierre ; Arnaud, Emilie...
Advances in Radiation Oncology. 9 (2024) 3 - p. 101384 , 2024

Link: https://doi.org/10.1016/..

5

Trastuzumab deruxtecan in previously treated HER2‐positive ..:

Petit, Thierry ; Hajjaji, Nawale ; Antoine, Eric‐Charles...
Cancer Medicine. 13 (2024) 9 - p. , 2024

Link: https://doi.org/10.1002/..

6

Fulvestrant and everolimus efficacy after CDK4/6 inhibitor:..:

Vasseur, Antoine ; Cabel, Luc ; Hego, Caroline...
Oncogene. 43 (2024) 16 - p. 1214-1222 , 2024

Link: https://doi.org/10.1038/..

7

Sacituzumab govitecan in metastatic triple-negative breast ..:

De Moura, Alexandre ; Loirat, Delphine ; Vaillant, Sarah...
Breast Cancer. 31 (2024) 4 - p. 572-580 , 2024

Link: https://doi.org/10.1007/..

8

[18F]FDG PET/CT for predicting triple-negative breast cance..:

Seban, Romain-David ; Arnaud, Emilie ; Loirat, Delphine...
European Journal of Nuclear Medicine and Molecular Imaging. 50 (2023) 13 - p. 4024-4035 , 2023

Link: https://doi.org/10.1007/..

9

Author Correction: Paclitaxel plus carboplatin and durvalum..:

Buisseret, Laurence ; Loirat, Delphine ; Aftimos, Philippe...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

10

Real-World Impact of Adjuvant Anti-HER2 Treatment on Charac..:

Le Du, Fanny ; Carton, Matthieu ; Bachelot, Thomas...
The Oncologist. 28 (2023) 10 - p. e867-e876 , 2023

Link: https://doi.org/10.1093/..

11

Health-related quality of life in the phase III ASCENT tria..:

Loibl, Sibylle ; Loirat, Delphine ; Tolaney, Sara M....
European Journal of Cancer. 178 (2023) - p. 23-33 , 2023

Link: https://doi.org/10.1016/..

12

Paclitaxel plus carboplatin and durvalumab with or without ..:

Buisseret, Laurence ; Loirat, Delphine ; Aftimos, Philippe...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

13

Atezolizumab and paclitaxel as first line therapy in advanc..:

de Moura, Alexandre ; Vuagnat, Perrine ; Renouf, Benjamin...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

14

Overall survival with sacituzumab govitecan in hormone rece..:

Rugo, Hope S ; Bardia, Aditya ; Marmé, Frederik...
The Lancet. 402 (2023) 10411 - p. 1423-1433 , 2023

Link: https://doi.org/10.1016/..

15

Analysis of patients without and with an initial triple-neg..:

O'Shaughnessy, Joyce ; Brufsky, Adam ; Rugo, Hope S....
Breast Cancer Research and Treatment. 195 (2022) 2 - p. 127-139 , 2022

Link: https://doi.org/10.1007/..